Bicocca Open Archive

Logo unimib boa
POZZI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.335
EU - Europa 4.256
AS - Asia 2.422
SA - Sud America 201
AF - Africa 47
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.249
IT - Italia 1.108
SG - Singapore 1.090
DE - Germania 839
RU - Federazione Russa 715
CN - Cina 590
SE - Svezia 492
IE - Irlanda 353
HK - Hong Kong 250
BR - Brasile 178
GB - Regno Unito 171
VN - Vietnam 121
AT - Austria 115
ID - Indonesia 91
FI - Finlandia 90
UA - Ucraina 86
CA - Canada 75
DK - Danimarca 72
IN - India 68
FR - Francia 66
JP - Giappone 45
NL - Olanda 45
TR - Turchia 37
KR - Corea 34
BE - Belgio 28
EG - Egitto 21
AU - Australia 14
ES - Italia 14
TW - Taiwan 14
IR - Iran 13
MY - Malesia 10
CH - Svizzera 8
CZ - Repubblica Ceca 8
PK - Pakistan 8
TH - Thailandia 8
ZA - Sudafrica 8
EU - Europa 7
RO - Romania 7
UZ - Uzbekistan 7
EC - Ecuador 6
HR - Croazia 6
IL - Israele 6
RS - Serbia 6
AR - Argentina 5
BG - Bulgaria 5
MX - Messico 5
SA - Arabia Saudita 5
BD - Bangladesh 4
DZ - Algeria 4
LV - Lettonia 4
NG - Nigeria 4
PL - Polonia 4
BN - Brunei Darussalam 3
BO - Bolivia 3
IQ - Iraq 3
PT - Portogallo 3
PY - Paraguay 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BH - Bahrain 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
PH - Filippine 2
AL - Albania 1
AZ - Azerbaigian 1
CL - Cile 1
CM - Camerun 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
UY - Uruguay 1
Totale 12.283
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.750
Singapore 717
Frankfurt am Main 526
Milan 439
Dublin 343
Wilmington 343
Chandler 329
Hong Kong 247
Dearborn 229
Ashburn 205
New York 181
Santa Clara 172
Woodbridge 152
Princeton 134
Fairfield 130
Houston 126
Munich 113
Nanjing 110
Vienna 105
Jakarta 85
Shanghai 76
Seattle 74
Jacksonville 71
Helsinki 68
Guangzhou 63
Boardman 61
Beijing 51
Dong Ket 49
Carate Brianza 38
Chicago 36
Rome 34
Los Angeles 33
Moscow 33
Nanchang 30
Nuremberg 30
Cambridge 29
Lawrence 29
Pune 29
Altamura 28
Shenyang 28
Melzo 27
Toronto 26
Tokyo 22
Falls Church 21
Shangdi 21
Brussels 20
Ottawa 20
Hangzhou 17
Andover 16
Council Bluffs 16
Mainz 16
Sacramento 16
Hägersten 15
Kunming 15
São Paulo 15
Codroipo 14
Edmonton 14
Florence 14
Tianjin 14
Yuseong-gu 14
Dallas 13
Hyderabad 13
Jinan 13
Lissone 13
Zhengzhou 13
London 12
San Diego 12
Fremont 11
Jiaxing 11
Norristown 11
Norwalk 11
Washington 11
Romola 10
Sesto San Giovanni 10
Canazei 9
Changsha 9
Kiev 9
Lappeenranta 9
Piemonte 9
Rio de Janeiro 9
Bangkok 8
Bologna 8
Cagliari 8
Ningbo 8
Brno 7
Düsseldorf 7
Grafing 7
Hebei 7
Miami 7
Tashkent 7
Trieste 7
Como 6
Genoa 6
Hefei 6
Perugia 6
Tainan City 6
Taizhou 6
6th of October City 5
Amsterdam 5
Bergamo 5
Totale 8.029
Salva come PNG Salva come JPEG
Nome #
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 338
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 313
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 307
OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY IN MOUSE MODELS: DIFFERENT TREATMENT SCHEDULES AND FOCUS ON OXIDATIVE STRESS 282
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 253
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 240
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 234
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 231
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 230
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 220
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 214
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 209
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 208
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 207
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 203
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 203
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 194
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 194
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 194
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 186
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 182
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 174
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 168
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 165
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 165
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 160
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 156
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 150
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 149
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 146
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 145
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 144
Multimodal experimental approach to the study of human neurological diseases 143
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 143
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 143
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 142
Genetic factors influencing the development of vincristine-induced neurotoxicity 142
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 136
CIPN and its mechanism of development 135
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 135
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 134
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 133
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 132
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 131
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 129
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 128
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 127
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 127
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 124
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 122
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 117
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 115
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 113
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 113
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 112
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 109
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 107
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 107
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 107
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 106
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 104
Oxaliplatin-Induced Peripheral Neurotoxicity: a Role for Genomics? 104
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 104
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 103
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 102
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 101
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 100
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 99
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 99
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 98
Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity 96
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 93
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 92
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 91
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN) 85
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 85
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 84
Can different Mice Strains be differently susceptible to Oxaliplatin-Induced Peripheral Neuropathy? 83
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 80
null 80
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 77
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY 75
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 73
REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI 73
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 72
Oxaliplatin neurotoxicity: morpho-functional approach 70
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 69
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 67
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 67
High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models 64
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 64
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 63
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 61
Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity 56
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 56
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 53
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 50
The different susceptibility to oxaliplatin neurotoxicity in mice is related to change in expression of the anion exchanger SLC4A1 50
In vivo study of Carfilzomib-Induced Neuropathy 49
Totale 13.168
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020266 0 0 0 0 0 0 0 0 0 143 102 21
2020/20212.017 47 63 231 207 156 223 220 236 157 103 140 234
2021/20221.106 111 133 110 97 93 104 49 49 44 52 79 185
2022/20231.884 187 371 239 174 166 306 63 75 136 41 82 44
2023/20241.561 69 61 73 92 156 358 246 104 77 39 47 239
2024/20253.998 241 501 470 235 403 283 438 187 578 662 0 0
Totale 13.168